December 6, 2023
11 a.m. to 12:30 p.m.
Gain invaluable insights into the FDA interaction process for early-stage biotechs developing therapeutic or medicinal products. This webinar will cover crucial topics such as when and how to approach the FDA, available meeting types, expected responses, data package requirements for an FDA IND request, and the significance of a well-crafted regulatory strategy.
- Zeb Younes, Head of Product Development & Regulatory Consulting, Principal Consultant
- Dan Cafaro, Principal Consultant
Read about the topics covered in the webinar flyer or review image below.